Publications by authors named "Jhanelle E Gray"

69Publications

RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry.

Lung Cancer 2021 Jan 14;153:90-98. Epub 2021 Jan 14.

Department of Medicine, Division of Medical Oncology, Duke University School of Medicine, Durham, NC, 27710, USA; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, 27710, USA. Electronic address:

View Article and Find Full Text PDF
January 2021

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer.

Front Oncol 2020 17;10:1783. Epub 2020 Nov 17.

Moffitt Cancer Center, Tampa, FL, United States.

View Article and Find Full Text PDF
November 2020

Non-invasive decision support for NSCLC treatment using PET/CT radiomics.

Nat Commun 2020 10 16;11(1):5228. Epub 2020 Oct 16.

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article and Find Full Text PDF
October 2020

Locally Advanced, Unresectable Non-Small Cell Lung Cancer.

Curr Oncol Rep 2020 03 5;22(4):31. Epub 2020 Mar 5.

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

View Article and Find Full Text PDF
March 2020

Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer.

Eur J Cancer 2020 01 12;125:49-57. Epub 2019 Dec 12.

Department of Oncology, University of Turin, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Turin, Italy. Electronic address:

View Article and Find Full Text PDF
January 2020

Radiomics of F-FDG PET/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy.

Eur J Nucl Med Mol Imaging 2020 05 5;47(5):1168-1182. Epub 2019 Dec 5.

Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.

View Article and Find Full Text PDF
May 2020

Overall Survival with Osimertinib in Untreated, -Mutated Advanced NSCLC.

N Engl J Med 2020 01 21;382(1):41-50. Epub 2019 Nov 21.

From Winship Cancer Institute, Emory University School of Medicine, Atlanta (S.S.R.); the Respiratory Oncology Unit, Department of Respiratory Medicine, University Hospital KU Leuven, Leuven, Belgium (J.V.); the Thoracic Unit, Department of Medical Oncology, Institut Gustave Roussy, Villejuif (D.P., J.-C.S.), and University Paris Sud, Orsay (J.-C.S.) - both in France; the Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul (B.C.C.), and the Division of Medical Oncology, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju (K.H.L.) - both in South Korea; the Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (J.E.G.); the Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo (Y.O.), the Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka (F.I.), and the Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka (T.K.) - all in Japan; Pulmonary Hospital of Tongji University, Shanghai (C.Z.), and Jilin Provincial Cancer Hospital, Changchun (Y.C.) - both in China; the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok (T.R.), and the Oncology Unit, Department of Medicine, Chiang Mai University, Chiang Mai (B.C.) - both in Thailand; Kent Oncology Centre, Maidstone Hospital, and Tunbridge Wells NHS Trust, Maidstone (R.S.), and Late Oncology Statistics (A.T., R.H.) and Oncology Research and Development (M.S., Y.R.), AstraZeneca, Cambridge - both in the United Kingdom; Hospital Regional Universitario Málaga, Instituto de Investigación Biomédica de Málaga, Malaga, Spain (M.C.); William Osler Health System, University of Toronto, Toronto (P.C.); the Department of Medicine and Surgery, University of Parma and Medical Oncology Unit, University Hospital of Parma, Parma, Italy (M.T.); the Department of Medical Oncology, Austin Health, Melbourne, VIC, Australia (T.J.); the Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan (M.-C.L.); and Early Oncology Research and Development, AstraZeneca, Gaithersburg, MD (J.-C.S.).

View Article and Find Full Text PDF
January 2020

Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial.

Transl Cancer Res 2019 Jul;8(Suppl 4):S404-S420

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

View Article and Find Full Text PDF
July 2019